Keith S. Sia
Kensington, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
A recombinant antibody fragment directed to the thymic stromal lymphopoietin receptor (CRLF2) efficiently targets pediatric Philadelphia chromosome-like acute lymphoblastic leukemia.
Journal: International journal of biological macromolecules
Published: May 31, 2021
Targeting TSLP-Induced Tyrosine Kinase Signaling Pathways in CRLF2-Rearranged Ph-like ALL.
Journal: Molecular cancer research : MCR
Published: November 12, 2019
Optimization of a clofarabine-based drug combination regimen for the preclinical evaluation of pediatric acute lymphoblastic leukemia.
Journal: Pediatric blood & cancer
Published: August 25, 2019
Evaluation of the in vitro and in vivo efficacy of the JAK inhibitor AZD1480 against JAK-mutated acute lymphoblastic leukemia.
Journal: Molecular cancer therapeutics
Published: December 16, 2014
Combined targeting of JAK2 and Bcl-2/Bcl-xL to cure mutant JAK2-driven malignancies and overcome acquired resistance to JAK2 inhibitors.
Journal: Cell reports
Published: September 28, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026